Biology Reference
In-Depth Information
[39] Amir AL, van der Steen DM, Hagedoorn RS, Kester MG, van Bergen CA, Drijfhout JW,
et al. Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide
specific. Blood 2011;118(26):6733-42.
[40] Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia
effect. Nat Rev Cancer 2004;4(5):371-80.
[41] Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J, et al. Mismatches of
minor histocompatibility antigens between HLA-identical donors and recipients and
the development of graft-versus-host disease after bone marrow transplantation.
N Engl J Med 1996;334(5):281-5.
[42] Nuchtern JG, Biddison WE, Klausner RD. Class II MHC molecules can use the endog-
enous pathway of antigen presentation. Nature 1990;343(6253):74-6.
[43] Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol
2005;5(12):953-64.
[44] Segura E, Villadangos JA. Antigen presentation by dendritic cells in vivo. Curr Opin
Immunol 2009;21(1):105-10.
[45] Sancho D, Joffre OP, Keller AM, Rogers NC, Martinez D, Hernanz-Falcon P, et al.
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity.
Nature 2009;458(7240):899-903.
[46] Kurts C, Robinson BWS, Knolle PA. Cross-priming in health and disease. Nat Rev
Immunol 2010;10(6):403-14.
[47] Yewdell JW. Designing CD8+ T cell vaccines: it's not rocket science (yet). Curr Opin
Immunol 2010;22(3):402-10.
[48] Amigorena S, Savina A. Intracellular mechanisms of antigen cross presentation in
dendritic cells. Curr Opin Immunol 2010;22(1):109-17.
[49] Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki
S, et al. Differential antigen processing by dendritic cell subsets in vivo. Science
2007;315(5808):107-11.
[50] Zhang Y, Louboutin JP, Zhu J, Rivera AJ, Emerson SG. Preterminal host dendritic cells
in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J Clin
Invest 2002;109(10):1335-44.
[51] Li H, Demetris AJ, McNiff J, Matte-Martone C, Tan HS, Rothstein DM, et al. Profound
depletion of host conventional dendritic cells, plasmacytoid dendritic cells, and B cells
does not prevent graft-versus-host disease induction. J Immunol 2012;188(8):3804-11.
[52] Hashimoto D, Chow A, Greter M, Saenger Y, Kwan WH, Leboeuf M, et al. Pretransplant
CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic
hematopoietic cell transplantation. J Exp Med 2011;208(5):1069-82.
[53] Markey KA, Banovic T, Kuns RD, Olver SD, Don AL, Raffelt NC, et al. Conventional
dendritic cells are the critical donor APC presenting alloantigen after experimental
bone marrow transplantation. Blood 2009;113(22):5644-9.
[54] Korngold R, Sprent J. T-cell subsets and graft-versus-host-disease. In: Burakoff SJ, Deeg
HJ, Ferrara J, Atkinson K, editors. Graft-Versus-Host Disease. New York: Dekker; 1990.
p. 31-50.
[55] Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, et al. Risk
factors for acute GVHD and survival after hematopoietic cell transplantation. Blood
2012;119(1):296-307.
[56] Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, Hurley CK, et al. HLA-
identical sibling compared with 8/8 matched and mismatched unrelated donor
bone marrow transplant for chronic phase chronic myeloid leukemia. J Clin Oncol
2009;27(10):1644-52.
[57] Sprent J, Miller JF, Mitchell GF. Antigen-induced selective recruitment of circulating
lymphocytes. Cell Immunol 1971;2(2):171-81.
[58] Kosaka H, Surh CD, Sprent J. Stimulation of mature unprimed CD8+ T cells by
semiprofessional antigen-presenting cells in vivo. J Exp Med 1992;176(5):1291-302.
[59] Gao EK, Kosaka H, Surh CD, Sprent J. T cell contact with Ia antigens on nonhemopoietic
cells in vivo can lead to immunity rather than tolerance. J Exp Med 1991;174(2):435-46.
[60] Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR, et al. Acute
graft-versus-host disease does not require alloantigen expression on host epithelium.
Nat Med 2002;8(6):575-81.
[61] Jones SC, Murphy GF, Friedman TM, Korngold R. Importance of minor histocompat-
ibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated
graft-versus-host disease model. J Clin Invest 2003;112(12):1880-6.
[62] Matte-Martone C, Liu J, Jain D, McNiff J, Shlomchik WD. CD8+ but not CD4+ T cells
require cognate interactions with target tissues to mediate GVHD across only minor
H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to
mediate GVL. Blood 2008;111(7):3884-92.
190
Search WWH ::
Custom Search